被 發 現 含 有 未 標 示 西 藥 的 產 品
|
| |
| Australia: Sexual enhancement supplements found to contain undeclared prescription medicines (English only) |
| |
The Therapeutic Goods Administration (TGA) is advising consumers that several sexual enhancement products have been found to contain undeclared ingredients and may pose a serious risk to your health. The affected products are:
- Nano Volume capsules (Contains undeclared tadalafil)
- Lustra 80 tablets (Contains undeclared tadalafil)
- Candy Power For Man lozenges (Contains undeclared tadalafil)
- Kama Exstasy200 tablets (Contains undeclared sildenafil)
- Kama Super Platinum tablets (Contains undeclared sildenafil and dapoxetine)
- Nano Epigen Size capsules (Contains undeclared tadalafil)
- Rock II Hard tablets (Contains undeclared tadalafil)
- Cobra Max capsules (Contains undeclared sildenafil)
- Black Bull Extreme cream (Contains undeclared sildenafil and tadalafil)
- Gold Lion tablets (Contains undeclared tadalafil)
- Black Cat capsules (Contains undeclared sildenafil and tadalafil)
TGA laboratory testing of several sexual enhancement products that claimed to be dietary supplements or natural formulas has confirmed the products contained undeclared prescription-only substances sildenafil, tadalafil and dapoxetine.
The presence of these prescription-only substances was not declared on the product labels. None of the products are included in the Australian Register of Therapeutic Goods and have not been assessed by the TGA for quality, safety or efficacy, as required under Australian legislation.
Consumers are advised to stop using the products and take any remaining product to their local pharmacy for safe disposal. If they have any concerns arising from their use of these products, consult their healthcare practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/safety/safety-monitoring-and-information/../sexual-enhancement-supplements-found-contain-undeclared-prescription-medicines
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Monday, Jun 29, 2026
Issued at HKT 12:15
|
| |
